BioWorld

Dec. 22, 2008

View Archived Issues

Ignoring Shareholders Puts Industry Investment at Risk

Back in early October, the future was looking pretty good for Avigen Inc. Its stock was trading above $3 and it was awaiting data on lead program AV562, with plans for additional pipeline programs down the road. Read More

Money Raised Year to Date

Read More

Stock Winners and Losers For The Week

Read More

Biotechnology Company Deals with Other Biotechnology Companies: Oct. 24 - Dec. 18, 2008

Read More

Biotechnology Company Deals with Miscellaneous Companies: Oct. 24 - Dec. 18, 2008

Read More

Manufacturing, Marketing and Distribution Agreements Between Biotech Companies: Oct. 24 - Dec. 18, 2008

Read More

Biotech-Biotech Collaborations: Modified Agreements: Oct. 24 - Dec. 18, 2008

Read More

BioWorld Stock Report For Public Biotechnology Companies

Read More